相关实验视频
Updated: Jun 17, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
用小分子疗法管理中度至重度性结肠炎患者的实践指南
Vipul Jairath1, Waqqas Afif2, Brian Bressler3
1Division of Gastroenterology, Western University, St. Joseph's Health Care, London, ON, Canada.
新的小分子疗法,包括-1酸盐 (S1P) 受体调节剂和Janus激活激酶抑制剂,为加拿大的性结肠炎 (UC) 管理提供了先进的治疗选择.
科学领域:
- 胃肠道学和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种严重的,进展性胃肠道疾病,严重影响加拿大人的生活质量.
- 有效的UC长期管理需要先进的治疗策略.
- 目前的治疗方法旨在控制炎症并调节免疫反应.
研究的目的:
- 为利用性结肠炎 (UC) 新型小分子疗法提供实际指导.
- 突出斯芬戈-1-酸盐 (S1P) 受体调节剂和Janus激活激酶 (JAK) 抑制剂在UC治疗中的作用.
- 审查新兴的小分子疗法作为UC的治疗策略.
主要方法:
- 本综述综合了关于UC小分子疗法的当前文献.
- 它专注于S1P受体调节器和JAK抑制剂.
- 为优化治疗管理提供了指导.
主要成果:
- 小分子疗法针对独特的途径,是UC免疫病理学的核心.
- S1P受体调节剂和JAK抑制剂为减轻炎症提供了新的方法.
- 这些疗法代表了UC的新兴治疗策略.
结论:
- 小分子疗法,包括S1P受体调节器和JAK抑制剂,为UC管理提供了先进的选择.
- 这些向疗法可以有效调节UC的免疫反应.
- 优化使用这些药物对于改善患者长期治疗结果至关重要.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...